FindTrial
Sign In

A study of efficacy of nerve block by phenol vs botulinum toxin motor point block in case of post stroke upper limb tightness

A comparative study between efficacy of phenol chemoneurolysis vs onabotulinum toxin motor point block in post stroke upper limb spasticity. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091682
Enrollment
82
Registered
2025-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I699- Sequelae of unspecified cerebrovascular diseases

Interventions

Intervention1: Phenol Chemoneurolysis: At first teflon coated needle connected to nerve stimulator guided to specific motor branch of the muscle.Specific muscle contraction observed at 0.5 ma to 09.2

Sponsors

Institute of post graduate medical education and research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically and radiologically confirmed any stroke. Spasticity at MAS scale 2/3. Brunnstorm stage recovery 3-4

Exclusion criteria

Exclusion criteria: Local site infection. Contracture of UL. Allergy to phenol or botulinum toxin

Design outcomes

Primary

MeasureTime frame
Phenol block will be statistically significant than botulinum toxin in terms of MAS,wrist rom and modified frenchey scaleTimepoint: Phenol block will be statistically significant than botulinum toxin in terms of MAS,wrist rom and modified frenchey scale at baseline,24 hr,2wk,12 wk—

Secondary

MeasureTime frame
NILTimepoint:—

Countries

India

Contacts

Public ContactRajesh Pramanik

IPGMER AND SSKM,KOLKATA

rpramanik2000@yahoo.com9432594882

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026